Papillary Renal Cell Carcinoma - 26 Studies Found Active, not recruiting : Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer : Adult Acute Myeloid Leukemia in Remission Childhood Acute Lymphoblastic Leukemia in Remissio : 2001-12-07 : Drug: Fludarabine Phosphate Gi Active, not recruiting : Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer : Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi : 2000-06-02 : Drug: fludarabine phosphate Gi Recruiting : A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma : Renal Cell Carcinoma Clear-cell Renal Cell Carcinoma : 2016-07-13 : Drug: CDX-014 Completed : Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer : Chromophobe Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Biological: Bevacizumab Given Completed : Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors : Childhood Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Drug: Doxorubicin Hydrochloride RECRUITING : Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial : Metastatic Papillary Renal Cell Carcinoma : 2024-05-21 : Given IV <<< Previous